Investor Relations


    Back to Videos

    Sernova Fact Sheet


    2017 / Sep 11




    Latest Updates

    July 18, 2018

    2018 Financial Report - 2nd Quarter

    June 29, 2018

    2018 Management Discussion & Analysis (MD&A) - 2nd Quarter

    May 28, 2018

    Corporate Presentation

    April 2018

    March 29, 2018

    2018 Financial Report - 1st Quarter

    March 29, 2018

    2018 Management Discussion & Analysis (MD&A) - 1st Quarter

    December 11, 2017

    Clearance by FDA of Sernova's US IND

    Conference call audio recording

    September 11, 2017

    Sernova Fact Sheet

    AGM Documents

    Please download the related documents

    2018 Sernova AGM Circular document

    PDF file

    2018 Sernova AGM Proxy document

    PDF file

    Corporate Governance


    Please read the related documents

    Insider Trading Compliance Policy

    PDF file

    Whistleblower Policy

    PDF file

    Analyst Coverage


    Sernova and its securities are covered by the following investment firms. This list of investment firms is being provided solely for your information and convenience and does not constitute an endorsement of or concurrence with any information, opinions, estimates, forecasts or recommendations provided by any of the investment firms listed below by Sernova. Furthermore, Sernova does not distribute information or reports prepared by analysts. The following list includes analysts currently known by Sernova Corp. to follow the company but may not be complete or up to date and may change without notice. Sernova undertakes no obligation to update and maintain this list. Please refer to the Legal Notice on this website for further information.




    Analyst

    Douglas Loe

    Firm

    Echelon Wealth Partners

    Phone

    1-888-216-9779 ext 501

    Stock Price


    Please Note: All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Sernova nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.